Received Feb 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (JANSSEN)) | JANSSEN | UNK | Unknown | — |
chest pains; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height and weight were not reported. Age at time of vaccination was unknown. No past medical history, concurrent conditions or pre-existing medical conditions were reported. The patient received janssen covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose and frequency not reported, administered on Jun-2021, additional dosage information included: Dose series 1, for covid-19 prophylaxis. The batch number was not reported. Company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On Jun-2021, the patient experienced chest pains. (Dose series: 1). The patient had chest pains immediately after the Covid vaccine in June 2021 for 12weeks. The action taken with janssen covid-19 vaccine was not applicable. The outcome of chest pains was not reported. This report was non-serious.